Don't miss the first Talakayang HeaRT Beat this 2022!

To start this year's series of press conferences, we highlight previous winners of DOST-PCHRD Health Research Awards and their impacts to the health of Filipinos. Join us:
26 January 2022, 10AM-12PM
bit.ly/THBJan_Reg

See you!

#healthresearchph #dostpchrd

#DOSTintheNEWS

The Regional Health Research and Development Consortium in Davao Region (RHRDC-XI) is looking for health-related research proposals that will receive funding from the Department of Science and Technology (DOST).

Up to PHP1 million funding per project proposal will be allocated for researchers from RHRDC-XI member institutions, like the Davao Medical School Foundation and the University of the Philippines Mindanao.

Normally, about half of the average 10 to 15 proposals yearly get approval with a project cost that ranges from PHP500,000 to PHP1 million.

Full story:
https://www.pna.gov.ph/articles/1165457

#DOSTintheNEWS

A medical doctor and project leader of the study on lagundi as adjuvant therapy for mild Covid-19 reminded the public that there is a prescribed dosage for the herbal medicine that treats cough and asthma.

Department of Science and Technology (DOST) Secretary Fortunato de la Peña, in a taped report aired Friday afternoon, said the prescribed dosages will ensure that treatment using lagundi will render positive results.

Citing the recommendations of Dr. Cecilia Maramba-Lazarte, the project leader of the lagundi clinical trial by the University of the Philippines Manila with the support from DOST-Philippine Council for Health Research and Development, he said adults may take the 600-milligram (mg) tablet or 5 milliliters (ml) of the 600 mg syrup thrice daily.

Full story:
https://www.pna.gov.ph/articles/1165495